Compositions comprising enzymecleavable ketone-modified opioid prodrugs and optional inhibitors thereof

Details for Australian Patent Application No. 2010293028 (hide)

Owner Signature Therapeutics, Inc.

Inventors Jenkins, Thomas E.; Husfeld, Craig O.; Seroogy, Julie D.; Wray, Jonathan W.

Agent FB Rice

Pub. Number AU-A-2010293028

PCT Pub. Number WO2011/031350

Priority 61/288,148 18.12.09 US; 61/240,611 08.09.09 US

Filing date 21 April 2010

Wipo publication date 17 March 2011

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

C07D 489/02 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/031350 Priority application(s): WO2011/031350

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010293032-Efficient service discovery for peerto-peer networking devices

2010293023-Trim manifold assembly for a sprinkler system